Company
AstriVax Therapeutics
Ending virus-driven cancer
Also known as Astrivax Therapeutics N.V.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Leuven, Belgium
- Legal name
- Astrivax Therapeutics N.V.
Claim, correct or request removal
Record updated 28 September 2026
About
Astrivax Therapeutics (Astrivax) is a clinical-stage biopharmaceutical company on a mission to end virus-driven cancer, the second leading preventable cause of cancer after smoking. Its clinically validated Launch-iT platform generates durable, antigen-specific T-cell responses that clear virus-infected cells, supported by a scalable, tech-transfer–ready manufacturing process.
Funding snapshot
- Latest round
- Seed
Funding rounds
- Grant
- Recorded
- Seed
- Recorded
Loading relationship preview